Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Award presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases honours UK researcher for his distinguished body of work in the epidemiology of musculoskeletal disorder

Source: International Osteoporosis Foundation

Cyrus CooperThe 2014 ESCEO-IOF Servier Pierre D. Delmas Prize was awarded today to Cyrus Cooper, Professor of Musculoskeletal Science at the University of Oxford and Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit, Vice-Dean of the Faculty of Medicine at the University of Southampton. 

Presented at the opening of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Seville, Spain, the prestigious annual Prize honours an outstanding researcher who has made major scientific contributions to the study of bone and mineral diseases. The Prize, granted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) with the support of Servier is valued at 40,000 EUR.

Presenting the Prize in Seville, Professor Bess Dawson Hughes, IOF General Secretary, commented “We are delighted to present this award to one of the field’s most distinguished scientists and educators. Cyrus Cooper has been identified recently as among the 400 most influential biomedical researchers worldwide and the highest ranked within the bone field. His body of work has made essential contributions across several key areas. Most notably, his pioneering clinical studies on the developmental origins of peak bone mass have provided invaluable insights that impact on a wide spectrum of research within the field.”

Professor Cooper leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. Key research contributions have included the discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; characterization of the definition and incidence rates of vertebral fractures; and leadership of large randomized controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture. Professor Cooper is Chairman of the IOF Committee of Scientific Advisors; Chair of the MRC Population Health Sciences Research Network; Associate Director of Research at the University of Southampton Medical School; and Associate Editor of the journal Osteoporosis International. He has published over 630 research papers on osteoporosis and rheumatic disorders.

Similar stories

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.